Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Rebecca J. Grant-Klein | Researchclopedia

Back to researchers

Rebecca J. Grant-Klein

Merck & Co., Inc., Rahway, NJ, USA (United States)

13

Works

405

Citations

11

h-index

11

i10-index

Research Topics

Viral Infections and Outbreaks Research Viral Infections and Vectors Viral gastroenteritis research and epidemiology

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)2017–2022

United States Army Medical Research Institute of Infectious Diseases2010–2015

United States Army Medical Research and Development Command2012–2015

Top Works

Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges

Rebecca J. Grant-Klein,Louis A. Altamura,et al.

201574 citations

Hepatitis B Virus Studies

COVID-19 epidemiological studies

Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults

Scott A. Halperin,Rituparna Das,et al.

201953 citations

Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic

Beth-Ann Coller,Jeffrey T. Blue,et al.

201749 citations

A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge

Rebecca J. Grant-Klein,Nicole M. Van Deusen,et al.

201245 citations

Rapid identification of vector-borne flaviviruses by mass spectrometry

Rebecca J. Grant-Klein,Carson Baldwin,et al.

201042 citations

Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses

Rebecca J. Grant-Klein,Louis A. Altamura,et al.

201134 citations

Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials

Rebecca F. Grais,Stephen B. Kennedy,et al.

202133 citations

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials

Jakub K. Simon,Stephen B. Kennedy,et al.

202225 citations

Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus – Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis

Joseph M. Antonello,Rebecca J. Grant-Klein,et al.

202017 citations